세계의 동맥 캐뉼라 시장 - 규모, 점유율, 동향 분석 보고서 : 용도별, 사이즈별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Arterial Cannula Market Size, Share & Trends Analysis Report By Application (ECMO, Cardiopulmonary Bypass Surgery), By Size (20-22 Fr, 35-36 Fr), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,287,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,679,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,465,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

동맥 캐뉼라 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계 동맥 캐뉼라 시장 규모는 2025-2030년 중에 CAGR 7.5%를 기록하며, 2030년에는 3,340만 달러에 달할 것으로 예측됩니다.

만성 질환의 유병률 증가는 수술 증가로 이어지고, 이는 산업의 성장을 견인합니다. 국립의료도서관이 2020년 9월에 발표한 내용에 따르면, 매년 3억 1,000만건의 대수술이 진행되고 있으며, 유럽에서는 약 2,000만건, 미국에서는 약 4,000-5,000만건에 이르고 있습니다. 또한, 낮은 침습 수술의 진보가 제품 수요를 견인하고 있습니다. 낮은 침습 기술과 최첨단 기술을 통해 환자는 회복이 빠르고 통증이 적으며 최상의 미적 결과를 얻을 수 있습니다.

이러한 장점은 낮은 침습 기술의 채용을 증가시키고 이러한 수술적 개입을 받기로 선택하는 환자를 증가시킵니다. COVID-19의 유행으로 인해 제품 매출이 일시적으로 감소했습니다. 이는 바이러스의 확산을 피하기 위해 선택적 수술을 연기하고 COVID-19 바이러스 대책에 전념했기 때문입니다. 그러나 유행의 후반에는 의료 전문가의 노력이 증가하고 미시 경제 수준뿐만 아니라 거시 경제 수준에서도 다양한 전략이 시작되어 시장이 빠르게 회복되기 시작했습니다. 앞으로 비슷한 사태를 피하기 위해 각국 정부가 의료에 힘을 쏟고 있어 예측기간 중에도 큰 수요가 예상되고 있습니다. 게다가, 의료 부문에 대한 투자 증가도 예측 기간 동안 산업 전체의 성장을 뒷받침할 것으로 기대됩니다.

동맥 캐뉼라 시장 보고서 하이라이트

• ECMO 부문은 산소 공급을 위한 동맥 캐뉼라의 채용 증가로 2024년에 가장 높은 수익 점유율을 차지했습니다.
• 심장 질환의 유병률이 증가함에 따라, 심폐 우회 수술 부위는 예측 기간 동안 가장 빠른 CAGR을 경험할 것으로 예상됩니다.
• 20-22Fr 크기의 부문은 가장 일반적으로 사용되는 동맥 캐뉼라이기 때문에 2024년 수익 점유율로 시장을 선도했습니다.
• 병원 부문은 2024년에 가장 큰 점유율을 차지했습니다.
• ASC 부문은 다양한 정부의 유리한 상환 이니셔티브로 인해 예측 기간 동안 가장 빠른 성장률을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 동맥 캐뉼라 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 동맥 캐뉼라 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 동맥 캐뉼라 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 동맥 캐뉼라 시장 : 용도 변동 분석
• 동맥 캐뉼라 시장의 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 심폐 우회 수술
• 체외식 막형 인공폐(ECMO)
• 기타

제5장 동맥 캐뉼라 시장 : 사이즈별, 추정·동향 분석

• 부문 대시보드
• 동맥 캐뉼라 시장 : 사이즈 변동 분석
• 동맥 캐뉼라 시장의 크기별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

제6장 동맥 캐뉼라 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 동맥 캐뉼라 시장 : 최종 용도 변동 분석
• 동맥 캐뉼라 시장의 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 병원
• 외래수술센터(ASC)
• 기타

제7장 동맥 캐뉼라 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 지역별 동맥 캐뉼라 시장 변동 분석
• 동맥 캐뉼라 시장 : 지역별, 추정·동향 분석 2018-2030년
• 2018-2030년 시장 규모와 예측과 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
  • 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
  • 라틴아메리카
  • 브라질
  • 아르헨티나
  • 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • Medtronic, plc.
  • LivaNova plc
  • Edward Lifesciences
  • Getinge AB
  • Fresenius Medical Care
  • BD
  • Nipro Corp.
  • Andocor
  • Freelife Medical GmbH
  • Surgical Holdings
  • Kangxin Medical

JHS

영문 목차

영문목차

Arterial Cannula Market Growth & Trends:

The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research. An increase in the prevalence of chronic diseases is leading to a rise in surgical procedures, which is driving the growth of the industry. According to an article published by the National Library of Medicine in September 2020, an overwhelming 310 million major surgeries are performed each year; around 20 million in Europe and about 40 to 50 million in the USA. Furthermore, advancements in minimally invasive surgeries are driving product demand. Minimally invasive techniques and cutting-edge technology give patients fast recovery time, less pain, and the best aesthetic results.

These advantages have resulted in the increasing adoption of minimally invasive techniques, which is leading to an increasing number of patients opting to undergo these surgical interventions. The COVID-19 pandemic resulted in a temporary fall in product sales. This is due to the postponement of elective surgeries to avoid the spread of the virus and focus dedicatedly on combatting the COVID-19 virus. However, the market began to quickly recover in the second half of the pandemic with increasing efforts of healthcare professionals and different strategies led down at the micro as well as macro-economic levels. The industry is further expected to experience significant demand over the forecast period with governments of various countries majorly focusing on healthcare to avoid similar situations in the future. Moreover, increasing investments in the healthcare sector are also expected to boost the overall industry growth over the forecast period.

Arterial Cannula Market Report Highlights:

• The ECMO segment held the highest revenue share in 2024 owing to the increasing adoption of the arterial cannula for oxygenation
• The cardiopulmonary bypass surgery segment is projected to experience the fastest CAGR over the forecast period due to the increasing prevalence of cardiac diseases
• The 20-22 Fr size segment led the market, in terms of revenue share in 2024 as these are the most commonly used arterial cannulas
• The hospitals segment held the largest share in 2024 as the majority of surgical procedures are carried out in these settings
• The ASCs segment will register the fastest growth rate over the forecast period due to favorable reimbursement initiatives by various governments

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Size
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Size outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Arterial Cannula Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Increasing geriatric population
    • 3.2.1.3. Rise in number of surgical procedures
    • 3.2.1.4. Advancements in minimally invasive surgeries
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Product recalls
• 3.3. Arterial Cannula Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Arterial Cannula Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Arterial Cannula Market: Application Movement Analysis
• 4.3. Arterial Cannula Market by Application Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Cardiopulmonary Bypass Surgery
  • 4.5.1. Cardiopulmonary Bypass Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Extracorporeal Membrane Oxygenation (ECMO)
  • 4.6.1. Extracorporeal Membrane Oxygenation (ECMO) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Arterial Cannula Market: Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Arterial Cannula Market: Size Movement Analysis
• 5.3. Arterial Cannula Market by Size Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. 14-16 Fr
  • 5.5.1. 14-16 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. 17-19 Fr
  • 5.6.1. 17-19 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. 20-22 Fr
  • 5.7.1. 20-22 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. 23-25 Fr
  • 5.8.1. 23-25 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. 26-28 Fr
  • 5.9.1. 26-28 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. 29- 31 Fr
  • 5.10.1. 29- 31 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. 32-34 Fr
  • 5.11.1. 32-34 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.12. 35-36 Fr
  • 5.12.1. 35-36 Fr Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Arterial Cannula Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Arterial Cannula Market: End use Movement Analysis
• 6.3. Arterial Cannula Market by End use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Arterial Cannula Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Arterial Cannula Market Movement Analysis
• 7.3. Arterial Cannula Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1 Key Country Dynamics
    • 7.5.7.2 Competitive Scenario
    • 7.5.7.3 Regulatory Framework
    • 7.5.7.4 Reimbursement scenario
    • 7.5.7.5 UK Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1 Key Country Dynamics
    • 7.5.8.2 Competitive Scenario
    • 7.5.8.3 Regulatory Framework
    • 7.5.8.4 Reimbursement scenario
    • 7.5.8.5 Germany Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1 Key Country Dynamics
    • 7.5.9.2 Competitive Scenario
    • 7.5.9.3 Regulatory Framework
    • 7.5.9.4 Reimbursement scenario
    • 7.5.9.5 France Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1 Key Country Dynamics
    • 7.5.10.2 Competitive Scenario
    • 7.5.10.3 Regulatory Framework
    • 7.5.10.4 Reimbursement scenario
    • 7.5.10.5 Italy Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1 Key Country Dynamics
    • 7.5.11.2 Competitive Scenario
    • 7.5.11.3 Regulatory Framework
    • 7.5.11.4 Reimbursement scenario
    • 7.5.11.5 Spain Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1 Key Country Dynamics
    • 7.5.12.2 Competitive Scenario
    • 7.5.12.3 Regulatory Framework
    • 7.5.12.4 Reimbursement scenario
    • 7.5.12.5 Denmark Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1 Key Country Dynamics
    • 7.5.13.2 Competitive Scenario
    • 7.5.13.3 Regulatory Framework
    • 7.5.13.4 Reimbursement scenario
    • 7.5.13.5 Sweden Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1 Key Country Dynamics
    • 7.5.14.2 Competitive Scenario
    • 7.5.14.3 Regulatory Framework
    • 7.5.14.4 Reimbursement scenario
    • 7.5.14.5 Norway Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.15. Asia Pacific
  • 7.5.16. Asia Pacific Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.17. Japan
    • 7.5.17.1 Key Country Dynamics
    • 7.5.17.2 Competitive Scenario
    • 7.5.17.3 Regulatory Framework
    • 7.5.17.4 Reimbursement scenario
    • 7.5.17.5 Japan Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.18. China
    • 7.5.18.1 Key Country Dynamics
    • 7.5.18.2 Competitive Scenario
    • 7.5.18.3 Regulatory Framework
    • 7.5.18.4 Reimbursement scenario
    • 7.5.18.5 China Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.19. India
    • 7.5.19.1 Key Country Dynamics
    • 7.5.19.2 Competitive Scenario
    • 7.5.19.3 Regulatory Framework
    • 7.5.19.4 Reimbursement scenario
    • 7.5.19.5 India Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.20. South Korea
    • 7.5.20.1 Key Country Dynamics
    • 7.5.20.2 Competitive Scenario
    • 7.5.20.3 Regulatory Framework
    • 7.5.20.4 Reimbursement scenario
    • 7.5.20.5 South Korea Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.21. Australia
    • 7.5.21.1 Key Country Dynamics
    • 7.5.21.2 Competitive Scenario
    • 7.5.21.3 Regulatory Framework
    • 7.5.21.4 Reimbursement scenario
    • 7.5.21.5 Australia Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.22. Thailand
    • 7.5.22.1 Key Country Dynamics
    • 7.5.22.2 Competitive Scenario
    • 7.5.22.3 Regulatory Framework
    • 7.5.22.4 Reimbursement scenario
    • 7.5.22.5 Thailand Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.23. Latin America
  • 7.5.24. Latin America Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.25. Brazil
    • 7.5.25.1 Key Country Dynamics
    • 7.5.25.2 Competitive Scenario
    • 7.5.25.3 Regulatory Framework
    • 7.5.25.4 Reimbursement scenario
    • 7.5.25.5 Brazil Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.26. Argentina
    • 7.5.26.1 Key Country Dynamics
    • 7.5.26.2 Competitive Scenario
    • 7.5.26.3 Regulatory Framework
    • 7.5.26.4 Reimbursement scenario
    • 7.5.26.5 Argentina Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.27. Middle East & Africa
  • 7.5.28. Middle East & Africa Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.29. South Africa
    • 7.5.29.1 Key Country Dynamics
    • 7.5.29.2 Competitive Scenario
    • 7.5.29.3 Regulatory Framework
    • 7.5.29.4 Reimbursement scenario
    • 7.5.29.5 South Africa Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.30. Saudi Arabia
    • 7.5.30.1 Key Country Dynamics
    • 7.5.30.2 Competitive Scenario
    • 7.5.30.3 Regulatory Framework
    • 7.5.30.4 Reimbursement scenario
    • 7.5.30.5 Saudi Arabia Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.31. UAE
    • 7.5.31.1 Key Country Dynamics
    • 7.5.31.2 Competitive Scenario
    • 7.5.31.3 Regulatory Framework
    • 7.5.31.4 Reimbursement scenario
    • 7.5.31.5 UAE Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.32. Kuwait
    • 7.5.32.1 Key Country Dynamics
    • 7.5.32.2 Competitive Scenario
    • 7.5.32.3 Regulatory Framework
    • 7.5.32.4 Reimbursement scenario
    • 7.5.32.5 Kuwait Arterial Cannula Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Medtronic, plc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Application benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. LivaNova plc
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Application benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Edward Lifesciences
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Application benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Getinge AB
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Application benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Fresenius Medical Care
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Application benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. BD
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Application benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Nipro Corp.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Application benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Andocor
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Application benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Freelife Medical GmbH
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Application benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Surgical Holdings
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Application benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Kangxin Medical
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Application benchmarking
    • 8.2.11.4. Strategic initiatives

관련자료